Warren Buffett’s Long-Term Dividend Holds: Sanofi SA (ADR) (SNY) and More
Warren Buffett has made a name for himself by snatching up companies at deep discounts and holding until he’s captured as much value as possible.
Glaxosmithkline Plc (GSK)
Market is closed
News
- First
- << Previous
- 381 - 390
- Next >>
Is Now the Time to Buy GlaxoSmithKline plc (GSK)?
So right now I am trawling through the FTSE 100 and giving my verdict on every member of the blue-chip index.
We Love You, Just Not Enough to Buy You (Yet): Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (SNY)
How much? Sanofi isn't saying, but it can't own more than $4.8 billion at current prices as long as the two companies remain partners because it's bound by a standstill agreement to not acquire more than...
Wall Street Loves Dynavax Technologies Corporation (DVAX). Should You?
Despite all of Wall Street's conflict and contention, a fortunate few companies enjoy unanimous support among professional analysts.
The Best Dividend in Big Pharma: Sanofi SA (SNY), Pfizer Inc. (PFE), GlaxoSmithKline plc (GSK)
Big pharma's a good place to start if you're looking for dividend stocks. Many of the largest players in the industry sport top dividends, rewarding long-term investors for their patience and faith.
Has GlaxoSmithKline plc (GSK) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Part 2: Three Dividend Stocks You Must Buy - GlaxoSmithKline plc (GSK), The Coca-Cola Company (KO)
Despite the uncertainties of Fiscal Cliff, dividend stocks have emerged as a rock solid investment.
Eli Lilly & Co. (LLY): If You're Going to Fail, Fail Quickly
It's not particularly surprising given that the drug failed a phase 3 trial in December, but it's still disappointing for a company that could really use a positive result.
Why I'm a Long-Term Investor in GlaxoSmithKline plc (GSK)
LONDON -- Back in 2007, I made the first of several purchases that together built up a small stake in GlaxoSmithKline plc (LSE:GSK) (NYSE:GSK) .
Gilead Sciences, Inc. (GILD) Earnings Blaze a Star-Studded Future
The global HIV market supports a large and lucrative business environment.
- First
- << Previous
- 381 - 390
- Next >>
Billionaire Hedge Funds
